From Molecular Target to Aptamer Drug Discovery towards US-FDA Orphan Drug Designation

Press/Media

Description

A range of articles on the titled designs

Period19 Dec 2022 → 20 Dec 2022

Media contributions

4

Media contributions

  • Title浸大研製「玻璃骨」適配子藥物
    Country/TerritoryHong Kong
    Date20/12/22
    Producer/Author文匯報
    PersonsYuanyuan YU, Ge ZHANG, Aiping LYU, Luyao WANG
  • Title分子標靶治玻璃骨新療法 浸大開發適配子藥 降中風危險
    Country/TerritoryHong Kong
    Date20/12/22
    Producer/Author信報
    PersonsYuanyuan YU, Ge ZHANG, Aiping LYU, Luyao WANG
  • Title浸大研發新藥 治骨質疏鬆 不增心血管病風險
    Country/TerritoryHong Kong
    Date20/12/22
    Producer/AuthorSkypost晴報
    PersonsYuanyuan YU, Ge ZHANG, Aiping LYU, Luyao WANG
  • Title浸大研新藥治骨質疏鬆症獲美國認證 比舊藥減引發心血管疾病機率
    Country/TerritoryHong Kong
    Date19/12/22
    PersonsYuanyuan YU, Ge ZHANG, Aiping LYU, Luyao WANG